ACIMEDIUM SIGNALFINANCIAL10-K

ACI shows mixed financial performance with improved balance sheet strength but declining profitability, while removing all merger-related language from risk factors.

The removal of merger-related risk factors and forward-looking statement language suggests the previously disclosed merger transaction is no longer pending or has been abandoned. This creates uncertainty about the company's strategic direction and removes a potential catalyst that investors may have been anticipating.

Comparing 2025-04-21 vs 2024-04-22View on EDGAR →
FINANCIAL ANALYSIS

ACI's balance sheet strengthened significantly with cash increasing 55.6% to $293.6M and total debt declining 10.8% to $9.8B, while stockholders' equity grew 23.2% to $3.4B, indicating improved financial stability. However, profitability deteriorated with net income falling 26% to $958.6M and operating income declining 25.3% to $1.5B, suggesting operational challenges despite the stronger balance sheet. The combination of deleveraging and cash accumulation alongside declining earnings creates a mixed picture that warrants investor attention.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+55.6%
$188.7M$293.6M

Cash position surged 55.6% — strong cash generation or capital raise providing significant financial cushion.

Net Income
P&L
-26%
$1.3B$958.6M

Net income declined 26% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-25.3%
$2.1B$1.5B

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Stockholders Equity
Balance Sheet
+23.2%
$2.7B$3.4B

Equity base grew 23.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Debt
Balance Sheet
-10.8%
$11.0B$9.8B

Debt reduced 10.8% — deleveraging strengthens balance sheet and reduces financial risk.

LANGUAGE CHANGES
NEW — 2025-04-21
PRIOR — 2024-04-22
ADDED
As of April 17, 2025, the registrant had 575,749,857 shares of Class A common stock, par value $0.01 per share, outstanding.
Our last three fiscal years consisted of the 52 weeks ended February 22, 2025 ("fiscal 2024"), the 52 weeks ended February 24, 2024 ("fiscal 2023") and the 52 weeks ended February 25, 2023 ("fiscal 2022").
Our next three fiscal years consist of the 53 weeks ending February 28, 2026 ("fiscal 2025"), the 52 weeks ending February 27, 2027 ("fiscal 2026") and the 52 weeks ending February 26, 2028 ("fiscal 2027").
The "forward-looking statements" include our current expectations, assumptions, estimates and projections about our business and our industry.
Risk Factors." NON-GAAP FINANCIAL MEASURES We define EBITDA as generally accepted accounting principles ("GAAP") earnings (net loss) before interest, income taxes, depreciation and amortization.
As of February 22, 2025, we operated 2,270 stores across 34 states and the District of Columbia under more than 20 well known banners including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, ACME, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets and Balducci's Food Lovers Market .
Additionally, as of February 22, 2025, we operated 1,728 in-store pharmacies, 1,313 in-store branded coffee shops, 405 associated fuel centers, 22 dedicated distribution centers, 19 manufacturing facilities and various digital platforms.
Our stores operate in premier locations and have leading market share within attractive and growing geographies.
We hold a #1 or #2 position by market share in 66% of the 122 metropolitan statistical areas ("MSAs") in which we operate.
Our Drive Up Go curbside pickup service and our delivery services are each offered in more than 2,200 of our stores.
REMOVED
As of April 18, 2024, the registrant had 577,407,663 shares of Class A common stock, par value $0.01 per share, outstanding.
Our last three fiscal years consisted of the 52 weeks ended February 24, 2024 ("fiscal 2023"), the 52 weeks ended February 25, 2023 ("fiscal 2022") and the 52 weeks ended February 26, 2022 ("fiscal 2021").
Our next three fiscal years consist of the 52 weeks ending February 22, 2025 ("fiscal 2024"), the 53 weeks ending February 28, 2026 ("fiscal 2025"), and the 52 weeks ending February 27, 2027 ("fiscal 2026").
The "forward-looking statements" include our current expectations, assumptions, estimates and projections about our business, our industry and the outcome of the Merger.
Risks Related to the Merger Risks related to: the Merger Agreement and the pendency of the Merger; restrictions on our business activities while the Merger Agreement is in effect; litigation related to the Merger; the ability to complete the Merger and the transactions contemplated by the Merger; and significant delay or the failure to complete the Merger.
Risks Related to Our Industry Risks related to: intensity of the competition in our industry; our ability to timely identify or effectively respond to consumer trends; consolidation in the healthcare industry; and providing pharmacy products and services and the adequacy of our insurance to cover any claims.
Risks Related to Our Workforce Risks related to: our relationship with unions, including labor disputes or work stoppages, and increased pension expenses, contributions and surcharges; increases to the minimum wage and changes to wage regulations; and the failure to attract and retain qualified associates.
Legal and Regulatory Risks Risks related to: unfavorable changes in government regulation and environmental laws; unfavorable changes in the tax code; legal or other proceedings; and our use of insurance and self-insurance to address potential liabilities.
Risks Related to Information Security, Cybersecurity, Data Privacy and Evolving Technologies Risks related to: our dependence on IT systems; improper activities by third parties and the loss of confidence from a data security incident involving our customers, employees or vendors; and the use of artificial intelligence in our business.
Risks Related to Our Indebtedness Risks related to: our level of indebtedness and our ability to generate cash; our debt instruments limiting our flexibility in operating our business; and increases in interest rates, a downgrade of our credit ratings and/or instability in credit markets.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →